Emerging Technologies in Infectious Diseases Diagnostics (Technical Insights)
This research service focuses on the emerging diagnostic technologies (for TB, HIV, HCV, HPV), the developmental initiatives, corporate developments by market leaders, and the role of international organizations within this market. It enlists end-user demands. The research service discusses the existing healthcare structure within the developing regions and the market impact of key innovations that influence the dynamics of the industry. It identifies the technology roadmap and technology management strategies. The research service also covers some of the key patents within the area.
Scope of Research
According to World Health Organization (WHO) “Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another.” Developing countries continue to experience the greatest impact from infectious diseases due to inadequate health care, malnutrition, poor sanitation and poor water quality.
A handful of deadly infectious diseases takes millions of lives in developing regions. The Sub-Saharan African regionsis the most vulnerable region and accounts for nearly half of the deaths from infectious disease globally. Asia and the Pacific regions are witnessing multidrug resistant TB with the increasing spread of HIV/AIDS in South and East Asia. The uneven economic development in Latin American has contributed to widespread resurgence of TB and HCV. The infectious diseases mentioned form a major socio economic healthcare burden in developing countries. A crucial approach that can relieve this burden is rapid diagnostic procedures.
Technologies for diagnosing infectious agents are used to evaluate the presence or absence of infection, and even to detect surrogate marker of infection. Diagnosing technologies are crucial for effective clinical management and for adopting appropriate disease control management. With access to central laboratory testing often being sparse or even non-existent, particularly in remote regions, POC testing can establish the diagnosis at the point of need and will play a key role in reducing the prevalence of infectious diseases in developing countries.
Electronic Access - Global Site License Fulfilled By Publisher
Electronic Access - Single User Fulfilled By Publisher